Header Logo

Michael Jelinek

TitleAssistant Professor
InstitutionRush University, Rush Medical College
DepartmentOncology
AddressChicago IL 60612
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    My ORCID number is 0000-0003-4959-2222.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Szewczyk C, Liao Y, Al-Khudari S, Jelinek MJ, Tatebe K. A Novel Immobilization Method for the Treatment of Head and Neck Cancer Using 3D Printing. Pract Radiat Oncol. 2024 Jan-Feb; 14(1):20-23. PMID: 37751796.
      Citations:    
    2. Mohamed MF, Al-Khudari S, Cassini-Vieira P, Erra A, Bagabas R, Houser T, Stenson K, Bhayani M, Jelinek MJ, Bishehsari F, Kuzel TM, Shafikhani SH. Presence of CrkI-containing microvesicles in squamous cell carcinomas could have ramifications on tumor biology and cancer therapeutics. Sci Rep. 2022 03 21; 12(1):4803. PMID: 35314778.
      Citations:    
    3. Bestvina CM, Pointer KB, Karrison T, Al-Hallaq H, Hoffman PC, Jelinek MJ, Juloori A, Melotek JM, Murgu S, Partouche J, Vokes EE, Weichselbaum RR, Pitroda SP, Patel JD, Chmura SJ. A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study. J Thorac Oncol. 2022 01; 17(1):130-140. PMID: 34500113.
      Citations:    
    4. Yudi MB, Clark DJ, Tsang D, Jelinek M, Kalten K, Joshi SB, Phan K, Ramchand J, Nasis A, Amerena J, Koshy AN, Murphy AC, Arunothayaraj S, Si S, Reid CM, Farouque O. SMARTphone-based, early cardiac REHABilitation in patients with acute coronary syndromes: a randomized controlled trial. Coron Artery Dis. 2021 Aug 01; 32(5):432-440. PMID: 32868661.
      Citations:    
    5. Jelinek MJ, Foster NR, Zoroufy AJ, Schwartz GK, Munster PN, Seiwert TY, de Souza JA, Vokes EE. A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101. Oral Oncol. 2021 03; 114:105171. PMID: 33513474.
      Citations:    
    6. Iyngkaran P, Thomas M, Horowitz JD, Komesaroff P, Jelinek M, Hare DL. Common Comorbidities that Alter Heart Failure Prognosis - Shaping New Thinking for Practice. Curr Cardiol Rev. 2021; 17(5):e160721187934. PMID: 33185169.
      Citations:    
    7. Jelinek MJ, Aggarwal C. Adjuvant Osimertinib: A New Standard of Care. Oncologist. 2021 04; 26(4):263-265. PMID: 33301209.
      Citations:    
    8. Jelinek M, Vale M. Implications of the UK Biobank prognostic study for preventive cardiology. Eur J Prev Cardiol. 2020 07; 27(10):1034-1035. PMID: 31795760.
      Citations:    
    9. Jelinek MJ, Vokes EE. Epidermal Growth Factor Receptor Blockade in Head and Neck Cancer: What Remains? J Clin Oncol. 2019 11 01; 37(31):2807-2814. PMID: 31483688.
      Citations:    
    10. Jelinek MJ, Armstrong SA, Patel JD, Subramaniam DS. Identifying Resistance Mechanisms to Osimertinib via Blood Biopsy. Clin Lung Cancer. 2019 11; 20(6):e597-e600. PMID: 31542322.
      Citations:    
    11. Coller JM, Gong FF, McGrady M, Jelinek MV, Castro JM, Boffa U, Shiel L, Liew D, Stewart S, Krum H, Reid CM, Prior DL, Campbell DJ. Age-specific diastolic dysfunction improves prediction of symptomatic heart failure by Stage B heart failure. ESC Heart Fail. 2019 08; 6(4):747-757. PMID: 31094087.
      Citations:    
    12. McNeil JJ, Wolfe R, Woods RL, Tonkin AM, Donnan GA, Nelson MR, Reid CM, Lockery JE, Kirpach B, Storey E, Shah RC, Williamson JD, Margolis KL, Ernst ME, Abhayaratna WP, Stocks N, Fitzgerald SM, Orchard SG, Trevaks RE, Beilin LJ, Johnston CI, Ryan J, Radziszewska B, Jelinek M, Malik M, Eaton CB, Brauer D, Cloud G, Wood EM, Mahady SE, Satterfield S, Grimm R, Murray AM. Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly. N Engl J Med. 2018 10 18; 379(16):1509-1518. PMID: 30221597.
      Citations:    
    13. Jelinek M, Hossack K. Implications of Cardio-Respiratory Fitness on the Performance of Exercise Tests. Heart Lung Circ. 2019 Apr; 28(4):e64-e66. PMID: 30269873.
      Citations:    
    14. Jelinek MJ, Howard AS, Haraf DJ, Vokes EE. Management of Early Head and Neck Cancer in Elderly Patients. J Oncol Pract. 2018 09; 14(9):541-546. PMID: 30285530.
      Citations:    
    15. Jelinek MJ, Lee SM, Wyche Okpareke A, Wing C, Koyner JL, Murray PT, Stadler WM, O' Donnell PH. Predicting Acute Renal Injury in Cancer Patients Receiving Cisplatin Using Urinary Neutrophil Gelatinase-Associated Lipocalin and Cystatin C. Clin Transl Sci. 2018 07; 11(4):420-427. PMID: 29691991.
      Citations:    
    16. Byrnes J, Elliott T, Vale MJ, Jelinek MV, Scuffham P. Coaching Patients Saves Lives and Money. Am J Med. 2018 04; 131(4):415-421.e1. PMID: 29106978.
      Citations:    
    17. Jelinek M, Kabelova A, Sramek J, Seitz J, Ojima I, Kovar J. Differing Mechanisms of Death Induction by Fluorinated Taxane SB-T-12854 in Breast Cancer Cells. Anticancer Res. 2017 04; 37(4):1581-1590. PMID: 28373418.
      Citations:    
    18. Jelinek MV, Thompson DR, Ski C, Bunker S, Vale MJ. 40 years of cardiac rehabilitation and secondary prevention in post-cardiac ischaemic patients. Are we still in the wilderness? Int J Cardiol. 2015 Jan 20; 179:153-9. PMID: 25464436.
      Citations:    
    19. Jelinek MV, Santamaria JD, Best JD, Thompson DR, Tonkin AM, Vale MJ. Reversing social disadvantage in secondary prevention of coronary heart disease. Int J Cardiol. 2014 Feb 15; 171(3):346-50. PMID: 24411209.
      Citations:    
    20. Krum H, Jelinek MV, Stewart S, Sindone A, Atherton JJ. 2011 update to National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand Guidelines for the prevention, detection and management of chronic heart failure in Australia, 2006. Med J Aust. 2011 Apr 18; 194(8):405-9. PMID: 21495941.
      Citations:    
    21. Jelinek M. Screening for depression in coronary heart disease: the perfect Hegelian dialectic? A short commentary on 'Beyond the blues: the need for integrated care pathways'. Eur J Cardiovasc Prev Rehabil. 2011 Apr; 18(2):222-3. PMID: 21450668.
      Citations:    
    22. Jelinek M, Barraclough K. Diagnosis in General Practice . Chest pain. BMJ. 2009 Nov 03; 339:b4117. PMID: 19887529.
      Citations:    
    Jelinek's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (136)
    Explore
    _
    Co-Authors (3)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _